Michigan Accelerator Fund
Michigan Accelerator Fund I has made a $750,000 Series A1 investment in Swift Biosciences Inc.
A medical device company with a new technique for fighting high blood pressure has won a $5.3 million preferred stock investment.
Michigan State University has licensed a suite of technologies to detect a broad range of pathogens and toxins to Michigan-based start-up nanoRETE. The company was launched by Michigan Accelerator Fund I (MAF-1), an investment partnership focused on Michigan-based early stage life science and technology companies.